Details

Autor(en) / Beteiligte

• Ghrenassia, G
• Grassion, L
• Molimard, M
• Sanchez-Pena, P
• Raherison, C

Titel

Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient

Ist Teil von

• Revue des maladies respiratoires, 2022-01, Vol.39 (1), p.55

Ort / Verlag

France

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Association of asthma with myasthenia gravis presents a twofold peculiarity. First, as dyspnea characterizes both conditions, diagnostic orientation is difficult. Second, from a therapeutic standpoint, the initiation of anticholinesterase treatment requires a multidisciplinary approach due to possible contraindication for asthma. We report on the case of a patient monitored for severe asthma and treated with biotherapy, and also monitored for myasthenia gravis, and treated with anticholinesterase.